Problem 147 - Cliffs Test Prep NCLEX-RN

Question

A patient is diagnosed with HIV. Which of the following are anti-viral drug classes used in the treatment of HIV/AIDS? 1\. Nucleoside Reverse Transcriptase Inhibitors 2\. Protease Inhibitors 3\. HIV Fusion Inhibitors 4\. all of the above

Step-by-Step Solution

Answer

The correct answer is option 4: all of the above.

Step 1: Understanding The Problem

The problem asks which drug classes are used in the treatment of HIV/AIDS. The options provided include several classes of drugs that target different stages of the viral life cycle.

Step 2: Examining Each Drug Class

Let's review each of the drug classes mentioned: 1. Nucleoside Reverse Transcriptase Inhibitors (NRTIs) block the reverse transcriptase enzyme, which HIV uses to make copies of itself. 2. Protease Inhibitors (PIs) interfere with the HIV protease enzyme that HIV needs to produce mature virus particles. 3. HIV Fusion Inhibitors prevent HIV from entering the host cells by blocking the fusion of the virus with the cell membrane.

Step 3: Identifying Drug Classes Used for HIV Treatment

All three drug classes listed are commonly used in the treatment of HIV. NRTIs, PIs, and HIV Fusion Inhibitors are part of the standard antiretroviral therapy (ART) regimens to manage HIV infection.

Step 4: Determining The Correct Answer

Since all the drug classes mentioned are used in HIV treatment, the correct answer is option 4: all of the above.

Key Concepts

Antiretroviral Therapy

Antiretroviral therapy (ART) is the cornerstone of HIV treatment. It is designed to control the virus and prevent its progression to AIDS, helping individuals maintain a healthy immune system.
ART involves a combination of drugs that act at different stages of the HIV life cycle.

• By using multiple drugs, ART reduces the viral load, which is the amount of HIV in the blood, to undetectable levels.
• It also helps prevent drug resistance, a common issue when the virus mutates.
• ART aims to improve the quality of life and extend life expectancy for those living with HIV.

Adherence to ART is crucial. Skipping doses can lead to drug resistance, reducing the therapy's efficacy. With consistent use, individuals can attain viral suppression, meaning the virus becomes undetectable and untransmittable.

Nucleoside Reverse Transcriptase Inhibitors

Nucleoside Reverse Transcriptase Inhibitors (NRTIs) are a key class of drugs in HIV treatment. They work by inhibiting reverse transcriptase, an enzyme crucial for HIV replication.
When HIV enters a cell, it needs to convert its RNA into DNA to replicate, and that’s where reverse transcriptase comes in.

• NRTIs mimic the building blocks of DNA, integrating into the viral DNA strand and preventing further synthesis.
• This action interrupts the virus's ability to replicate within the host cell, effectively limiting the spread.
• Common NRTIs include medications like zidovudine and emtricitabine.

NRTIs are usually combined with other drug classes for optimal effectiveness. They form the backbone of ART regimens.

Protease Inhibitors

Protease inhibitors (PIs) are another vital drug class in the fight against HIV. Their role is to disable the protease enzyme, hindering the production of mature virus particles.
After the virus replicates, the new copies need processing into final functional structures, a task protease enzymes perform.

• PIs block this enzyme, resulting in immature and non-infectious viral particles.
• By disrupting this critical step, PIs effectively reduce the viral load in the body.
• Some well-known PIs include drugs like lopinavir and ritonavir.

Both PIs and NRTIs are often included in ART regimens to ensure comprehensive treatment.

HIV Fusion Inhibitors

HIV Fusion Inhibitors are a unique class of antiretroviral drugs that work by blocking the virus from entering the host cell. By preventing fusion with the cell membrane, these inhibitors stop the virus right at the doorstep.

• Fusion inhibitors bind to proteins on the surface of the virus and the host cell, disrupting the ability of HIV to fuse with the cell membrane.
• This blockade prevents the virus from releasing its genetic material into the host cell, halting replication altogether.
• Enfuvirtide is one of the primary drugs in this category.

Fusion inhibitors are typically used alongside other drug classes in ART regimens to provide an effective barrier against HIV entry into cells.